Wednesday, October 22, 2014

The Boehringer Ingelheim Social Media Team Receives 5th Annual PharmaGuy Social Media Pioneer Award!

Yesterday, at Digital Pharma East Mobile Day, I officially announced the recipients of the 5th Annual PharmaGuy Social Media Pioneer Award, which recognizes a pharmaceutical executive or team who has “pioneered” in the use of social media for marketing, research, or corporate communications purposes.

This year's award goes to Patricia Alves (Social Media Community Manager), Jaclyn Fonteyne (Social Media Specialist), and Judith von Gordon (Head of Media + PR). View the slide presentation to find out why I chose Boehringer.



The BI Team sent me an entertaining, G-Rated, "Acceptance Movie" complete with outtakes!

Thursday, October 16, 2014

A Formula for Creating Patient-Centric Mobile Health Apps

In a previous Pharma Marketing Blog post, I explained Why I Will Be Attending Digital Pharma East. Now, I have an even better reason for being there:

On Mobile Day (October 21, 2014), I will present a "formula" for creating "patient-centric" mobile health (mHealth) apps.

My presentation will focus on what I learned from comments made by REAL patients in a recent poll I hosted in conjunction with Truvio and WEGO Health (see "Patient Activists Demand Higher Quality Mobile Health Apps").

The "formula" (see below) was inspired by a recent #mHealthPharma Tweet Chat that I moderated on October 9, 2014, at the request of the Mobile Health Competence Centre in Barcelona (find a StoryLine summary here).

So what is the "formula?"

Friday, October 10, 2014

#mHealtMobile Chat Takeaway: Pharma Must Involve Patients Early on When Developing Mobile Health Apps

Yesterday's hour-long #mHealthPharma TweetChat on how pharma can develop high quality mobile health apps was a great success. The following Storyline summary was prepared by Teresa Bau (@tbau_uoc), a freelance journalist from Barcelona & Mobile Health Global Editor. You can read my key takeaways below.


There were several "key takeaways" from this conversation that involved 45 participants from around the world. Keep reading to get my summary of the conversation.

Thursday, October 09, 2014

"Play by the Rules": Analysis of Ground Rules for 4HER Patient Connect App by Genentech

Genentech's 4HER iPhone App for women with HER2 breast cancer includes pages and pages and page of policies and terms and conditions that users are required to read (or at least agree to) before using the advanced features of the app. Yesterday, I reviewed the Privacy Policy (about 6 screens worth of text; see here). Today, I review the "Ground Rules" for the Patient Connect feature of the app.

Patient Connect allows users of the app to send email to other 4HER registered users located within a certain radius (e.g., 10 miles). You can select users you'd like to connect with based on a number of criteria that users enter when registering. Here's a view of those criteria:


As I mentioned yesterday, this app gives Genentech potential access to very, very sensitive personal health information coupled with location services, which raises a number of privacy and data security issues. I decided, therefore, not to reveal my dates of diagnoses nor my age group when I registered as "pharmagal." Unfortunately, Genentech doesn't know that I do not have HER2 breast cancer.

OK, so what are the "Ground Rules" for using the Patient Connect feature?

Wednesday, October 08, 2014

An Analysis of Genentech's 4HER Mobile Health App Privacy Policy

Genentech's 4HER iPhone App for women with HER2 breast cancer is interesting and perhaps unique in a Mobile Health App developed by a pharma company. The app allows users to send email to other registered users of the app and even notifies them of other users close by.

Here's the iTunes profile of the app:
As I mention in the above profile, there are privacy issues. So, I downloaded the app to read and analyze the privacy policy. My analysis reveals many interesting insights into how the personal information collected from this app will be used by Genentech.

#mHealthPharma TweetChat: What's Needed for Pharma to Develop Quality mHealth Apps?

Join me tomorrow, October 9, 2014, 12 noon Eastern U.S., for an hour-long TweetChat on how pharma can develop high quality mobile health apps. This is a followup to the debate I've been moderating on the LinkedIn Mobile Health Group (here) sponsored by the mHealth Competence Centre in Barcelona, Spain.

Whereas the LinkedIn debate frames this in a negative fashion ("what stands in the way..."), I prefer to frame the TweetChat more positively ("what's needed...") to have a more productive discussion.


The LInkedIn debate brought out more questions than answers. That debate helped me formulate the following questions/topics I hope to cover in the chat.

Related Posts Plugin for WordPress, Blogger...